In Vivo Proton MR Spectroscopy of Primary Tumours, Nodal and Recurrent Disease of the Extracranial Head and Neck

Overview

Journal Eur Radiol

Specialty Radiology

Date 2006 May 17

PMID 16703309

Citations 12

Authors

Sotirios Bisdas

Mehran Baghi

Frank Huebner

Cindy Mueller

Rainald Knecht

Marianne Vorbuchner

Jan Ruff

Wolfgang Gstoettner

Thomas J Vogl

Affiliations

Soon will be listed here.

Abstract

Benign and malignant neoplasms as well as metastatic lymph nodes of 39 patients were examined using localized single voxel magnetic resonance spectroscopy (MRS) [repetition time (TR) 1500, echo time (TE) 135) at 1.5 T. New techniques with simultaneous correction of motion artefacts during the acquisition, three-dimensional saturation pulses, respiratory triggering and smaller volume of interest (VOI) size, were applied. Ratios of peak areas under the choline (Cho) and creatine (Cr) resonances were estimated in all cases and compared with those from samples of normal tissue. Ninety one spectra were acquired in 39 patients, 63 of which were suitable for further evaluation. The smallest VOI was 0.40 cm(3). The Cho/Cr ratios in all malignant neoplasms (mean: 5.2, range: 1.7-17.8) were significantly elevated relative to those in the normal muscle structures (mean: 0.9, range: 0.2-1.4), while those in the benign neoplasms were elevated (mean: 24.4, range: 1.4-59.7) with respect to those in the malignant ones. The average Cho/Cr ratio in the metastatic lymph nodes was significantly higher (mean: 4.8, range: 3.3-5.6) than that for benign lymphoid hyperplasia (mean: 2.2, range: 1.0-3.0). MRS measurements were able to differentiate recurrent disease from post-therapeutic tissue changes in 11 out of 13 patients.

Citing Articles

Predictive value of 1H MR spectroscopy and 18F-FDG PET/CT for local control of advanced oropharyngeal and hypopharyngeal squamous cell carcinoma receiving chemoradiotherapy: a prospective study.

Yeh C, Lin G, Wang J, Lin C, Tsai S, Lin Y Oncotarget. 2018; 8(70):115513-115525.

PMID: 29383178 PMC: 5777790. DOI: 10.18632/oncotarget.23306.

Functional magnetic resonance imaging techniques and their development for radiation therapy planning and monitoring in the head and neck cancers.

Yuan J, Lo G, King A Quant Imaging Med Surg. 2016; 6(4):430-448.

PMID: 27709079 PMC: 5009093. DOI: 10.21037/qims.2016.06.11.

Differentiation of malignant cervical lymphadenopathy by dual-energy CT: a preliminary analysis.

Yang L, Luo D, Li L, Zhao Y, Lin M, Guo W Sci Rep. 2016; 6:31020.

PMID: 27498560 PMC: 4976355. DOI: 10.1038/srep31020.

Comparison of dual-energy CT-derived iodine content and iodine overlay of normal, inflammatory and metastatic squamous cell carcinoma cervical lymph nodes.

Tawfik A, Razek A, Kerl J, Nour-Eldin N, Bauer R, Vogl T Eur Radiol. 2013; 24(3):574-80.

PMID: 24081649 DOI: 10.1007/s00330-013-3035-3.

Current oncologic concepts and emerging techniques for imaging of head and neck squamous cell cancer.

Sadick M, Schoenberg S, Hoermann K, Sadick H GMS Curr Top Otorhinolaryngol Head Neck Surg. 2013; 11:Doc08.

PMID: 23320060 PMC: 3544205. DOI: 10.3205/cto000090.

References

Hurd R, Freeman D . Metabolite specific proton magnetic resonance imaging. Proc Natl Acad Sci U S A. 1989; 86(12):4402-6. PMC: 287277. DOI: 10.1073/pnas.86.12.4402. View

Hanaoka H, Yoshioka Y, Ito I, NIITU K, Yasuda N . In vitro characterization of lung cancers by the use of 1H nuclear magnetic resonance spectroscopy of tissue extracts and discriminant factor analysis. Magn Reson Med. 1993; 29(4):436-40. DOI: 10.1002/mrm.1910290403. View

Bolan P, Nelson M, Yee D, Garwood M . Imaging in breast cancer: Magnetic resonance spectroscopy. Breast Cancer Res. 2005; 7(4):149-52. PMC: 1175074. DOI: 10.1186/bcr1202. View

Majos C, Julia-Sape M, Alonso J, Serrallonga M, Aguilera C, Acebes J . Brain tumor classification by proton MR spectroscopy: comparison of diagnostic accuracy at short and long TE. AJNR Am J Neuroradiol. 2004; 25(10):1696-704. PMC: 8148728. View

Adalsteinsson E, Spielman D, Pauly J, Terris D, Sommer G, Macovski A . Feasibility study of lactate imaging of head and neck tumors. NMR Biomed. 1998; 11(7):360-9. DOI: 10.1002/(sici)1099-1492(1998110)11:7<360::aid-nbm518>3.0.co;2-p. View

Mukherji S, Schiro S, Castillo M, Kwock L, Muller K, Blackstock W . Proton MR spectroscopy of squamous cell carcinoma of the extracranial head and neck: in vitro and in vivo studies. AJNR Am J Neuroradiol. 1997; 18(6):1057-72. PMC: 8337295. View

Gerstle R, Aylward S, Mukherji S . The role of neural networks in improving the accuracy of MR spectroscopy for the diagnosis of head and neck squamous cell carcinoma. AJNR Am J Neuroradiol. 2000; 21(6):1133-8. PMC: 7973877. View

Mackinnon W, Barry P, Malycha P, Gillett D, Russell P, Lean C . Fine-needle biopsy specimens of benign breast lesions distinguished from invasive cancer ex vivo with proton MR spectroscopy. Radiology. 1997; 204(3):661-6. DOI: 10.1148/radiology.204.3.9280241. View

Wetter A, Hubner F, Lehnert T, Fliessbach K, Vorbuchner M, Roell S . Three-dimensional 1H-magnetic resonance spectroscopy of the prostate in clinical practice: technique and results in patients with elevated prostate-specific antigen and negative or no previous prostate biopsies. Eur Radiol. 2005; 15(4):645-52. DOI: 10.1007/s00330-004-2562-3. View

10.

Motoori K, Yamamoto S, Ueda T, Nakano K, Muto T, Nagai Y . Inter- and intratumoral variability in magnetic resonance imaging of pleomorphic adenoma: an attempt to interpret the variable magnetic resonance findings. J Comput Assist Tomogr. 2004; 28(2):233-46. DOI: 10.1097/00004728-200403000-00014. View

11.

King A, Yeung D, Ahuja A, Leung S, Tse G, Van Hasselt A . In vivo proton MR spectroscopy of primary and nodal nasopharyngeal carcinoma. AJNR Am J Neuroradiol. 2004; 25(3):484-90. PMC: 8158563. View

12.

Russell P, Lean C, Delbridge L, May G, Dowd S, Mountford C . Proton magnetic resonance and human thyroid neoplasia. I: Discrimination between benign and malignant neoplasms. Am J Med. 1994; 96(4):383-8. DOI: 10.1016/0002-9343(94)90071-x. View

13.

Mescher M, Merkle H, Kirsch J, Garwood M, Gruetter R . Simultaneous in vivo spectral editing and water suppression. NMR Biomed. 1998; 11(6):266-72. DOI: 10.1002/(sici)1099-1492(199810)11:6<266::aid-nbm530>3.0.co;2-j. View

14.

Law M, Hamburger M, Johnson G, Inglese M, Londono A, Golfinos J . Differentiating surgical from non-surgical lesions using perfusion MR imaging and proton MR spectroscopic imaging. Technol Cancer Res Treat. 2004; 3(6):557-65. DOI: 10.1177/153303460400300605. View

15.

Rutkowski T, Tarnawski R, Sokol M, Maciejewski B . 1H-MR spectroscopy of normal brain tissue before and after postoperative radiotherapy because of primary brain tumors. Int J Radiat Oncol Biol Phys. 2003; 56(5):1381-9. DOI: 10.1016/s0360-3016(03)00327-4. View

16.

Dowling C, Bollen A, Noworolski S, McDermott M, Barbaro N, Day M . Preoperative proton MR spectroscopic imaging of brain tumors: correlation with histopathologic analysis of resection specimens. AJNR Am J Neuroradiol. 2001; 22(4):604-12. PMC: 7976037. View

17.

Maheshwari S, Mukherji S, Neelon B, Schiro S, Fatterpekar G, Stone J . The choline/creatine ratio in five benign neoplasms: comparison with squamous cell carcinoma by use of in vitro MR spectroscopy. AJNR Am J Neuroradiol. 2000; 21(10):1930-5. PMC: 7974295. View

18.

Star-Lack J, Adalsteinsson E, Adam M, Terris D, Pinto H, Brown J . In vivo 1H MR spectroscopy of human head and neck lymph node metastasis and comparison with oxygen tension measurements. AJNR Am J Neuroradiol. 2000; 21(1):183-93. PMC: 7976356. View

19.

Barker P, Hearshen D, Boska M . Single-voxel proton MRS of the human brain at 1.5T and 3.0T. Magn Reson Med. 2001; 45(5):765-9. DOI: 10.1002/mrm.1104. View

20.

Mountford C, Lean C, Hancock R, Dowd S, Mackinnon W, Tattersall M . Magnetic resonance spectroscopy detects cancer in draining lymph nodes. Invasion Metastasis. 1993; 13(2):57-71. View